CD8A and myeloid sarcoma: This revealed a statistically significant decrease in the proportions of natural killer (NK) cells (meancase = 0.021, meancontrol = 0.031, p = 1.34 × 10−8) and CD8+ T cells (meancase = 0.095, meancontrol = 0.106, p = 5.92 × 10−5) and a statistically significant increase in the CD4+ T cell proportions (meancase = 0.081, meancontrol = 0.071, p = 1.58 × 10−3) in MS cases compared to controls.